Today's Daily Dose brings you news about FDA approval of Adamas' Gocovri for dyskinaesia in Parkinson's disease; Auris Medical's non-compliance with NASDAQ requirement; European Commission approval of Imraldi, a Humira biosimilar from Samsung BioLogics and Biogen; Genmab's promising phase III study results in multiple myeloma and Vertex Pharma's upcoming regulatory catalyst.
from RTT - Biotech http://ift.tt/2vuBjPR
via IFTTT
No comments:
Post a Comment